Skip to main content

Correction: Dec 9, 2004

Premium

In the 11/18/2004 Pharmacogenomics Reporter, the article “Diagnostics Eye Fragile-X Market After Wide Adoption of CF-Screen” incorrectly quoted Paul Billings, senior geneticist at LabCorp as saying “[Fragile-X testing] is clearly part of the standard of care for the workup of a child with proven environmental delay.” The quote should read: “[Fragile-X testing] is clearly part of the standard of care for the workup of a child with proven developmental delay.”

Filed under

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.